Pharmafile Logo

The challenges of conducting effective pharmaceutical market research in emerging markets

Published in Quirk’s Marketing Research Review, April 2016, By Marc Yates, Director of Emerging Markets


Emerging markets present an exciting opportunity for growth for the pharmaceutical industry, as traditional Western markets mature and there are a limited number of new products in the pipeline offering blockbuster revenues.

Some of the emerging markets, such as the BRIC nations of Brazil, Russia, India and China, are experiencing double-digit growth, as well as burgeoning public and private health care systems. A demographic of wealthy urban patients who can afford better-quality health care is on the rise, with an appetite for Western lifestyles and products.

http://www.researchpartnership.com/news/2016/05/article-best-practices-in-em/

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Webcast:

UX beyond the website: Insights for the age of omnichannel

News:

MedTech Qualitative Specialist joins Research Partnership

Guide

How to embrace behavioural science principles in healthcare MR

Article

A glimmer of hope for Alzheimer’s patients, but at what cost?

Video

Virtual Conference Live

Report

Digital Health Tools - Physician Trends

Webcast

Oncology landscape: How innovative market research methods can navigate you to success

Article:

The disparity of patient experiences with Crohn’s Disease in Europe and Japan

Research Partnership’s MedTech Division appoints two Directors

Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.

Webcast: Influencing HCP behaviours – Is now the perfect opportunity?

Putting behavioural science at the forefront of market research